Theravance Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
George Town, Grand Cayman, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Theravance Biopharma, Inc. has filed 1,125 SEC EDGAR filings since 01 Aug 2013

SEC filing history

Showing 976-1,000 of 1,000 matching filings.

Per page
25
Current page
40
8-K File 001-36033

8-K

Filing date
09 Sep 2015
Reporting date
09 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88552

SC 13G filing

Filing date
02 Sep 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-I File 005-88552

SC TO-I

Filing date
28 Aug 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-36033

8-K/A

Filing date
28 Aug 2015
Reporting date
10 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
24 Aug 2015
Reporting date
20 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
24 Aug 2015
Reporting date
20 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
24 Aug 2015
Reporting date
20 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36033

8-K

Filing date
19 Aug 2015
Reporting date
19 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
18 Aug 2015
Reporting date
18 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
18 Aug 2015
Reporting date
18 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
17 Aug 2015
Reporting date
13 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
17 Aug 2015
Reporting date
14 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36033

8-K

Filing date
12 Aug 2015
Reporting date
12 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36033

THERAVANCE BIOPHARMA, INC. 8-K

Filing date
10 Aug 2015
Reporting date
10 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-205275

EFFECT filing

Filing date
16 Jul 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
14 Jul 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
09 Jul 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-205275

S-3/A

Filing date
09 Jul 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
07 Jul 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-205275

S-3

Filing date
26 Jun 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-36033

CT ORDER filing

Filing date
22 Jun 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Jun 2015
Reporting date
02 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Jun 2015
Reporting date
02 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Jun 2015
Reporting date
02 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .